Description

The presentation objectives for this webinar will include: identifying strategies to better assist clinicians in understanding wellness, prevention and chronic disease management by using Reticulocycte Hemoglobin or RET-He. We will also discuss the RET-He threshold or cutoff values for defining iron availability in the apparently healthy reference population, as well as in populations at high risk for iron deficiency and iron deficiency anemia. Additionally, we will present published clinical studies that demonstrate the value of RET-He in monitoring iron deficiency, iron deficiency anemia, and Erythropoietin Stimulating therapy or ESA in key patient populations.

DURATION: 40 min